Advertisement

Abstract

At the time of diagnosis, patients with intrahepatic cholangiocarcinoma (ICC) are frequently found to have disease beyond the limits of surgical therapy, such the presence of intrahepatic satellite nodules, vascular invasion, or regional lymph-nodes metastases. In such patients, the resectability rate varies from 19 to 74% [1, 2, 3, 4] Moreover, exploratory laparotomy or R1 resection has a poor prognosis, with median patient survival of 5 months and postoperative complications of 17% [4] Consequently, palliative resection is not justified; instead, there is clearly a need to improve the assessment of resectability, in order to avoid unnecessary laparotomy and to develop an aggressive approach to obtain complete resection (R0).

Keywords

Hepatic Resection Negative Prognostic Factor Intrahepatic Cholangiocarcinoma Hepatoduodenal Ligament Intrahepatic Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Madariaga JR, Iwatsuki S, Todo S et al (1998) Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 227(1):70–79PubMedCrossRefGoogle Scholar
  2. 2.
    Yamanaka N, Okamoto E, Ando T et al (1995) Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer 76(12):2449–2456PubMedCrossRefGoogle Scholar
  3. 3.
    Lieser MJ, Barry MK, Rowland C et al (1998) Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience. J Hepatobiliary Pancreat Surg 5(1):41–47PubMedCrossRefGoogle Scholar
  4. 4.
    Lang H, Sotiropoulos GC, Fruhauf NR (2005) Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg. Jan 241(1):134–143Google Scholar
  5. 5.
    Weber SM, Jarnagin WR, Klimstra D (2001) Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 193(4):384–391PubMedCrossRefGoogle Scholar
  6. 6.
    Goere D, Wagholikar GD, Pessaux P et al (2006) Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc 20(5):721–725PubMedCrossRefGoogle Scholar
  7. 7.
    Cherqui D, Tantawi B, Alon R et al (1995) Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. Arch Surg 130(10):1073–1078PubMedGoogle Scholar
  8. 8.
    Harvey CJ, Blomley MJ, Eckersley RJ et al (2000) Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet 355(9206):807–808PubMedCrossRefGoogle Scholar
  9. 9.
    Skjoldbye B, Pedersen MH, Struckmann J et al (2002) Improved detection and biopsy of solid liver lesions using pulse-inversion ultrasound scanning and contrast agent infusion. Ultrasound Med Biol 28(4):439–444PubMedCrossRefGoogle Scholar
  10. 10.
    Isaji S, Kawarada Y, Taoka H et al (1999) Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6(2):108–116PubMedCrossRefGoogle Scholar
  11. 11.
    Harrison LE, Fong Y, Klimstra DS et al (1998) Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg 85(8):1068–1070PubMedCrossRefGoogle Scholar
  12. 12.
    Ohtsuka M, Ito H, Kimura F et al (2002) Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89(12):1525–1531PubMedCrossRefGoogle Scholar
  13. 13.
    Morimoto Y, Tanaka Y, Ito T et al (2003) Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10(6):432–440PubMedCrossRefGoogle Scholar
  14. 14.
    Huang IL, Biehl TR, Lee FT et al (2004) Outcomes after resection of cholangiocellular carcinoma. Am J Surg 187(5):612–617PubMedCrossRefGoogle Scholar
  15. 15.
    Nakagawa T, Kamiyama T, Kurauchi N et al (2005) Number of lymph-node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 29(6):728–733PubMedCrossRefGoogle Scholar
  16. 16.
    Yamamoto M, Takasaki K, Yoshikawa T et al (1998) Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol 69(3):162–167PubMedCrossRefGoogle Scholar
  17. 17.
    Inoue K, Makuuchi M, Takayama T et al (2000) Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 127(5):498–505PubMedGoogle Scholar
  18. 18.
    Shimada M, Yamashita Y, Aishima S et al (2001) Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88(11):1463–1466PubMedCrossRefGoogle Scholar
  19. 19.
    Shirabe K, Shimada M, Harimoto N et al (2002) Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 131(1 Suppl):S159–S164PubMedCrossRefGoogle Scholar
  20. 20.
    Sakamoto E, Hayakawa N, Kamiya J et al (1999) Treatment strategy for mucin-producing intrahepatic cholangiocarcinoma: value of percutaneous transhepatic biliary drainage and cholangioscopy. World J Surg 23(10):1038–1043; discussion 1043–1044PubMedCrossRefGoogle Scholar
  21. 21.
    Sasaki A, Aramaki M, Kawano K et al (1998) Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg 85(9):1206–1209PubMedCrossRefGoogle Scholar
  22. 22.
    Isa T, Kusano T, Shimoji H et al (2001) Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am. J. Surg 181(6):507–511PubMedCrossRefGoogle Scholar
  23. 23.
    Uenishi T, Yamazaki O, Yamamoto T et al (2005) Serosal invasion in TNM staging of massforming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 12(6):479–483PubMedCrossRefGoogle Scholar
  24. 24.
    Weinbren K, Mutum SS (1983) Pathological aspects of cholangiocarcinoma. J Pathol 139(2):217–238PubMedCrossRefGoogle Scholar
  25. 25.
    Casavilla FA, Marsh JW, Iwatsuki S et al (1997) Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 185(5):429–436PubMedGoogle Scholar
  26. 26.
    Tsuji T, Hiraoka T, Kanemitsu K et al (2001) Lymphatic spreading pattern of intrahepatic cholangiocarcinoma. Surgery 129(4):401–407PubMedGoogle Scholar
  27. 27.
    Uenishi T, Hirohashi K, Kubo S et al (2001) Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg 88(7):969–974PubMedCrossRefGoogle Scholar
  28. 28.
    Chu KM, Lai EC, Al-Hadeedi S et al (1997) Intrahepatic cholangiocarcinoma. World J Surg 21(3):301–305PubMedCrossRefGoogle Scholar
  29. 29.
    Murakami Y, Yokoyama T, Takesue Y (2000) Long-term survival of peripheral intrahepatic cholangiocarcinoma with metastasis to the para-aortic lymph nodes. Surgery 127(1):105–106PubMedCrossRefGoogle Scholar
  30. 30.
    Suzuki S, Sakaguchi T, Yokoi Y et al (2002) Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg 26(6):687–693PubMedCrossRefGoogle Scholar
  31. 31.
    Okami J, Dono K, Sakon M et al (2003) Patterns of regional lymph-node involvement in intrahepatic cholangiocarcinoma of the left lobe. J Gastrointest Surg 7(7):850–856PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Personalised recommendations